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Lifestyle Changes During 
the COVID-19 Pandemic 





• Brookfield Primary Care 
• Dr. Lauen Schedgick-Davis
Problem Identification and Need
Brookfield Primary Care (BPC)
Throughout the first two weeks of my clerkship experience at BPC, I sat in on or conducted many physical exams. Two components of the questioning 
series we asked were “how is your exercise and how is your diet?” We asked these questions to assess cardiovascular disease (CVD) risk in patients, 
which given the fact that CVD accounted for the most world-wide non-communicable disease deaths in 2012 with 17.5 million1, is an essential 
component of health maintenance. When asking these questions, a trend that I noticed was that patients would often say that as a result of the 
pandemic they had either began to eat more poorly and/or exercise less. These encounters made me think about what the potential ramifications of 
the shifting lifestyle choices, secondary to the pandemic may be on patients’ health and their risk for CVD. 
• > 30% of individuals in the USA aged 15-29 are 
categorized as being physically inactive2
• Higher consumption of ultra-processed food 
has been associated with cardiovascular, 
coronary artery, and cerebrovascular disease3
• Atherosclerotic vascular lesions of patients 
with higher BMI values are more frequent and 
advanced compared to subjects with normal 
body weight4
• CVD death is expected to remain the number 
one cause of death worldwide, with an 
expected annual death rate of 23.6 million by 
the year 20305
• In 2018, the state of CT had 7,205 deaths from 
CVD and 142.1 deaths per 100,000 individuals6
Public Health Cost
• In 2013, CVD accounted for the 2nd
highest personal health care 
spending in the United States7
• In 2010, CVD spending alone in the 
United states surpassed 300 billion 
dollars8
• The cost of cardiovascular disease 
has been shown to be higher than 
that of other chronic diseases9
• It is projected that 1 in 33 
Americans will have cardiovascular 
disease by the year 203010
Retrieved and adapted from https://jamanetwork.com/journals/jama/fullarticle/2594716





“At this rate, the impact of the 
current lifestyle choices that 
we are seeing trend due to 
COVID will be very significant. 
It is like a hamster wheel. 
COVID anxiety makes people 
cope poorly, and that poor 
coping results in health 
detriments that further the 






“I have definitely seen a drastic 
worsening in diet and exercise 
habits since COVID began. The 
thing is though, this did not change 
even with the summer months and 
the nice weather.  I feel as though 
COVID has brought a lot of 
underlying mental health troubles 
to the forefront and made it un-
ignorable, resulting in the 
utilization of poor coping 
mechanisms and lifestyle choices 
that are increasing CVD risk.”




for these patients and 
distributed to nursing 







Questionnaire consisted of an expansion of 2 standard items from the 
annual physical exam, with focus being on how the answers of those 
questions were changed by COVID-19
Response Data
Testimonials
• “With the children home from school and in need of child-care, I have not been able to get much 
time away from them, which has hindered my exercise regimen.”
• “With COVID, I have just lost motivation to maintain a healthy diet.”
• “Being around the house all day has made it so easy for me to just snack constantly.”
• “I think early on I got lost in all of the baking and became a bit complacent with the workouts.”
Effectiveness and Limitations
• Effectiveness
• Effectively collected 46 responses in one week by implementing intake screening
• Implementation of the following will bolster this study in the future
• Being selective with individuals that are screened based on BMI categories
• Matching responses to patients based on their weight changes at current annual physical in 
comparison to most recent physical
• Providing a space on the questionnaire for a freely written qualitative response
• Limitations
• Smaller sample size than preferred, due to cancellations and a vast portion of visits 
taking place on the telehealth platform
• Potentially inefficient assessment of diet with the focus being on fast food
• This was a difficult decision, as leaving the question open ended regarding improvement 
and/or regression of diet was considered, but the subjectivity of that format was thought to 
be ineffective
Recommendations for Future Interventions
A retrospective look 
at how patients’ 
BMIs changed 
before, during, and 
after the pandemic
A retrospective look 
at the rate of CVD in 
patients who lived 
through COVID-19
The development of a 
feasible exercise plan 
tailored for patients 
who do not have 
access to gyms and 
have children at home




snacks for those 
working from home
Here are some 
specific action steps 
and potential future 
studies, by which 
the care team can 
help curb the 
impact of COVID on 
CVD risk 
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